Efficacy and Safety of New B Cell-Targeted Biologic Agent for the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

Background: B cells are central to the pathogenesis of systemic lupus erythematosus (SLE). We aimed to analyze the efficacy and safety of new B cell-targeted drug therapies for SLE. Methods: A systematic review of randomized controlled trials (RCTs) and reference lists of relevant articles published...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Urquiza, José L., Romero-Bejar, José L., Chami-Peña, Sara, Suleiman-Martos, Nora, Cañadas-De la Fuente, Guillermo A., Molina, Esther, Riquelme-Gallego, Blanca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382055/
https://www.ncbi.nlm.nih.gov/pubmed/37510963
http://dx.doi.org/10.3390/jcm12144848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382055/
https://www.ncbi.nlm.nih.gov/pubmed/37510963
http://dx.doi.org/10.3390/jcm12144848

Ejemplares similares